Semprus BioSciences today announced it has received a $1 million grant from the U.S. Army Telemedicine & Advanced Technology Research Center (TATRC) to develop the world's first orthopedic devices designed to reduce biofilm formation.

Semprus BioSciences today announced it will host the final round of judging for the Life Sciences Track of the 2011 MIT $100K Entrepreneurship Competition on Monday, May 2.

Semprus BioSciences today announced its Chief Technology Officer Christopher Loose, Ph.D., will present the company's groundbreaking data results on its non-fouling Semprus Platform at SIR's 36th Annual Scientific Meeting.